Uniqure Nv
25/100
Smart-money confidence
Below average interest
No standout activity across the feeds we track.
Stocks scoring 25–45 beat the S&P 500 45.3% of the time over the next three months, since 2015. How we measured this →
7
hedge funds
hold it · 3 new, 3 added, 1 trimmed
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
Who's behind the signal
Every informed buyer we can see on UNIQURE NV, across all three feeds.
Hedge funds · 7
Tudor Investment (Paul Tudor Jones)
New position
Point72 (Steve Cohen)
New position
AQR Capital Management
New position
Maverick Capital (Ainslie)
Increased +33%
Citadel Advisors
Increased +125%
D.E. Shaw & Co
Increased +29%
+1 more in the full breakdown below ↓
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Not a model pick — but on our radar.
UNIQURE NV isn't in the top-10 model right now, but 7 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
7
Investors
3
New positions
3
Increasing
1
Decreasing
0
Unchanged
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.2×
% of portfolio
0.1%
Position change
NEW
0.1% of Tudor Investment's portfolio
Trust weight: 1.1×
% of portfolio
0.0%
Position change
NEW
0.0% of Point72's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
NEW
0.0% of AQR Capital Management's portfolio
Trust weight: 1.2×
% of portfolio
0.4%
Position change
+33%
0.4% of Maverick Capital's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
+125%
0.0% of Citadel Advisors's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
+29%
0.0% of D.E. Shaw & Co's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−57%
0.0% of Millennium Management's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to UNIQURE NV
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell UNIQURE NV or any security.